May 15, 2026
No Comments
Radiation oncology projects don’t all start at the same place. Some begin as ideas in markets where private radiation therapy has never existed. Others are already underway but drifting: financially, operationally, or both. And sometimes the most valuable outcome is realizing a project shouldn’t move forward at all.
What we’ve learned through leading cancer center development work is this: the starting point doesn’t matter nearly as much as whether the right expertise shows up at the right moment. In radiation oncology, the seams between finance, facility design, vendor coordination, and clinical operations are where projects succeed—or quietly unravel.
Below are three real examples that reflect one consistent approach: meet teams where they are and deliver clarity that protects capital, protects schedules, and protects access to care.
Not all development work fits a traditional U.S. playbook. One of the most meaningful projects we’ve supported involved two Radiation Oncologists seeking to establish the first privately owned radiation oncology center in Riyadh, Saudi Arabia.
Private radiation therapy did not exist in that market at the time. Approval depended on whether the physician group could credibly demonstrate that they understood what it takes to design, finance, build, and operate a radiation oncology center at an international standard.
Our role was to help them prove it.
We built a complete feasibility study and pro forma grounded in real radiation oncology operations—not optimism. That included adapting assumptions to local conditions, aligning staffing and throughput expectations, and working with architects and builders who had little prior experience with radiation oncology facilities.
During planning, we addressed issues that could have derailed the project, such as facility layout, workflow efficiency, and regulatory requirements that didn’t reflect the realities of how radiation therapy actually operates. The result was a plan that regulators, partners, and stakeholders could trust.
The physicians ultimately became the first non-government entity approved to own and operate a radiation oncology center in Riyadh. The center is now open and treating patients.
As they later shared:
“Radiation Business Solutions catalyzed our journey from a mere dream to a fully operational stand-alone radiation facility with their unparalleled expertise and unwavering support. From business planning assistance to workflow optimization, their comprehensive solutions ensured our success.”
This experience matters because it proves that true development expertise travels. It doesn’t depend on familiar regulations or geography; it depends on fundamentals, judgment, and adaptability.
Not every engagement starts at the beginning. In another case, a physician group initially selected a different consultant to guide their expansion into radiation oncology. Months into the process, the group lost confidence in the direction of the project and asked RBS to step in.
When we joined, the objective wasn’t to criticize prior work. It was to restore confidence quickly by addressing three areas that most often derail projects once momentum has already started:
In less than six weeks, we rebuilt the pro forma using realistic operational assumptions, joined calls with the architect and builder to identify unnecessary square footage and complexity, and helped eliminate approximately $500,000 in over-design that added cost without improving care.
We also engaged directly with the equipment vendor’s financing team to ensure funding terms aligned with the project’s true economics, and we met with the physician group’s board to clearly outline risks embedded in the existing plan.
As one of the physicians later reflected:
“Trip and his team brought a wealth of experience, which was crucial to building a pro forma with realistic revenue and expense projections. Their expertise helped remove over-design and negotiate with vendors, saving us over $500,000. We highly recommend RBS to any organization considering radiation oncology expansion.”
The larger lesson is simple: projects don’t stall because people don’t care; they stall because no one forces early alignment between the financial model, the facility design, and operational reality.
Here’s the part few firms talk about openly: sometimes the right answer is not to build.
In one rural-market feasibility effort, a physician group wanted a single partner who could take them end-to-end: feasibility, pro forma, project oversight, clinical setup, ongoing management, and billing. RBS had the capability to do all of it.
But after building a realistic pro forma and working with vendors to explore alternative solutions that might improve the economics, one conclusion remained unavoidable: the projected census, based on existing referral patterns, did not justify the fixed-cost investment unless those referral assumptions changed materially.
That wasn’t an easy conversation, but it was the responsible one.
Rather than pushing the project forward, we advised the group to pause unless conditions changed. The physicians later shared:
“Their thorough financial projections and objective recommendations helped us make informed decisions. Trip’s dedication to developing alternative solutions to reduce our risk demonstrated his commitment to our success. We highly recommend RBS for their expertise and integrity.”
This is the quiet differentiation. We’re not paid to move projects forward at all costs; we’re trusted to tell the truth about what it will take to succeed.
Different markets. Different starting points. Different outcomes.
The common thread is clarity.
In radiation oncology development, “meet you where you are” isn’t a slogan. It’s a disciplined way of working that protects schedules, capital, and patient access.
If you’re considering a radiation oncology project, or trying to rescue one, the most important question isn’t where you are today. It’s whether the guidance you’re receiving is grounded in reality.
